MDRX vs. TLS, OMCL, HSTM, CRTX, NXGN, EBIX, AGYS, VRNT, IONQ, and NTCT
Should you be buying Veradigm stock or one of its competitors? The main competitors of Veradigm include Telos (TLS), Omnicell (OMCL), HealthStream (HSTM), Cortexyme (CRTX), NextGen Healthcare (NXGN), Ebix (EBIX), Agilysys (AGYS), Verint Systems (VRNT), IonQ (IONQ), and NetScout Systems (NTCT).
Telos (NASDAQ:TLS) and Veradigm (NASDAQ:MDRX) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership, community ranking and valuation.
In the previous week, Veradigm had 1 more articles in the media than Telos. MarketBeat recorded 12 mentions for Veradigm and 11 mentions for Telos. Veradigm's average media sentiment score of 1.41 beat Telos' score of 0.25 indicating that Telos is being referred to more favorably in the media.
Veradigm has higher revenue and earnings than Telos.
Veradigm has a net margin of 0.00% compared to Veradigm's net margin of -22.22%. Telos' return on equity of 0.00% beat Veradigm's return on equity.
Telos has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, Veradigm has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500.
Telos currently has a consensus target price of $5.00, suggesting a potential upside of 10.38%. Veradigm has a consensus target price of $12.00, suggesting a potential upside of 26.32%. Given Telos' higher probable upside, analysts clearly believe Veradigm is more favorable than Telos.
62.1% of Telos shares are owned by institutional investors. 12.4% of Telos shares are owned by company insiders. Comparatively, 2.3% of Veradigm shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Veradigm received 579 more outperform votes than Telos when rated by MarketBeat users. However, 64.94% of users gave Telos an outperform vote while only 60.19% of users gave Veradigm an outperform vote.
Summary
Telos and Veradigm tied by winning 8 of the 16 factors compared between the two stocks.
Get Veradigm News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Veradigm Competitors List
Related Companies and Tools
